In addition to organic growth, UM Salama is committed to continued growth via acquisition, in-licensing new opportunities and forming mutually beneficial business partnerships.

Our management experience across a wide range of pharmaceutical products and markets allows rapid assessment of opportunities. At this stage in UM Salama's development we are willing to look at all therapeutic areas. We are focussed on products with sustainable sales that have proven demand. Many of these are prescription pharmaceuticals, but we also explore opportunities in semi-ethicals and related medical devices.

Acquisitions

UM Salama has an impressive and diverse deal history. Our acquisitions have been made from several of the world's top blue chip pharmaceutical companies, as well as various smaller ones.

We understand the value attributes of each product and business we acquire which have been developed over many years. We strive to maintain and improve asset equity. We have a well practiced and professional team with an integrated approach across finance, legal, manufacturing, regulatory and marketing. We aim to make the transfer as smooth as possible minimising the diversion of your resources and internal costs.

In Licensing

UM Salama is constantly considering a number of in-licensing opportunities. At this stage we will look at possibilities in all therapy areas.

If you are seeking a OMAN or International market entry partner, UM Salama's sales, marketing and regulatory expertise can help you navigate the whole process from marketing authorisation submission to field force deployment.

If you are considering divesting or partnering a product,
please contact us at :- admin@umsalama.com for an informal preliminary assessment.